000 01318 a2200385 4500
005 20250512195941.0
264 0 _c19830708
008 198307s 0 0 eng d
022 _a0312-5963
024 7 _a10.2165/00003088-198308030-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGreenblatt, D J
245 0 0 _aClinical pharmacokinetics of the newer benzodiazepines.
_h[electronic resource]
260 _bClinical pharmacokinetics
_c
300 _a233-52 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAlprazolam
650 0 4 _aAnti-Anxiety Agents
_xmetabolism
650 0 4 _aAzepines
_xmetabolism
650 0 4 _aBenzodiazepines
_xmetabolism
650 0 4 _aBenzodiazepinones
_xmetabolism
650 0 4 _aClobazam
650 0 4 _aHumans
650 0 4 _aKinetics
650 0 4 _aLorazepam
_xanalogs & derivatives
650 0 4 _aMidazolam
650 0 4 _aTemazepam
_xmetabolism
650 0 4 _aTriazolam
_xmetabolism
700 1 _aDivoll, M
700 1 _aAbernethy, D R
700 1 _aOchs, H R
700 1 _aShader, R I
773 0 _tClinical pharmacokinetics
_gvol. 8
_gno. 3
_gp. 233-52
856 4 0 _uhttps://doi.org/10.2165/00003088-198308030-00003
_zAvailable from publisher's website
999 _c6133759
_d6133759